Colorectal Cancer, Polyps
Conditions
Keywords
colorectal polyps, colorectal cancer, Virtual colonoscopy, Fecal tagging, MR colonography
Brief summary
The purpose of this study is to determine whether Barium or BariumFerumoxsil is better for fecal tagging in MR colonography. Patients referred to colonoscopy are offered MR colonography before colonoscopy. Two days before colonography, patients ingest either a contrast agent A (200 ml Barium sulphate solution 1g/ml)) four times a day or a 200 ml contrast agent B (Barium sulfate(25%) and Ferumoxil(75%)) four times a day, which will render fecal masses invisible on the following MR colonography. The patients are randomised to either contrast agent A or B. The examinations are evaluated by two independent blinded readers, who will rate the tagging quality of the contrast agents. The quality of tagging will be rated by a Visual Analog Scale (VAS) and Relative contrast (ReCon = Iwall - Ilumen/ Iwall + Ilumen).
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Suspicion of colorectal polyps or cancer * Referred for colonoscopy
Exclusion criteria
* Suspicion of IBD * Pacemaker * Metal in the body * Claustrophobia * Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity of VAS score vs. ReCon score | — |
| Quality of fecal tagging agent | — |
Countries
Denmark